Renaissance Investment Group’s Evogene EVGN Stock Holding History

Renaissance Investment Group’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$30.7K	–	80
2024 Q3	$30.7K	Buy	+10,000	New	+$43.1K	0.01%	85

Other funds holding EVGN

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Renaissance Investment Group's EVGN Position: Q4 2024 in Review

Renaissance Investment Group sold out of Evogene (EVGN) in Q4 2024, closing a stake of 10,000 shares — an estimated $30.7K sold.

Renaissance Investment Group first reported a position in EVGN in Q3 2024 and held it in 1 quarter. The position peaked at $30.7K in Q3 2024. 15 funds tracked by Wall St. Rank hold EVGN as of Q4 2024.

Renaissance Investment Group reported no remaining Evogene position as of Q4 2024 after selling out during the quarter.
Renaissance Investment Group sold 10,000 Evogene shares in Q4 2024, an estimated $30.7K.
Renaissance Investment Group first reported a position in Evogene in Q3 2024 and held it in 1 quarter.
Renaissance Investment Group's Evogene position peaked at $30.7K in Q3 2024.
15 funds tracked by Wall St. Rank held Evogene as of Q4 2024.

Based on Renaissance Investment Group's 13F filing for Q4 2024, filed 16 Jan 2025.